V2X
V2X, Inc.
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$4.5B
Operating marginCalculated
4.3%
Net assets to total assetsCalculated
33.1%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★★☆☆☆position among all companies
4.3%
Growth (revenue, 4-year average)
★★★★★position among all companies
25.9%
Capital efficiency
★★☆☆☆position among all companies
7.2%
Revenue and profit
Performance, financial position and capital allocation
V2X
Recent performance trends
V2X
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$1.8 billion | US$2.9 billion | US$4.0 billion | US$4.3 billion | US$4.5 billion |
| Operating income | US$62.02 million | US$55.77 million | US$0.1 billion | US$0.2 billion | US$0.2 billion |
| Net income | US$45.73 million | US$-14.33 million | US$-22.57 million | US$34.68 million | US$77.88 million |
| Total assets | US$0.9 billion | US$3.2 billion | US$3.1 billion | US$3.2 billion | US$3.3 billion |
| Shareholders' equity | US$0.4 billion | US$1.0 billion | US$1.0 billion | US$1.0 billion | US$1.1 billion |
| Net cash provided by (used in) operating activities | US$61.34 million | US$93.50 million | US$0.2 billion | US$0.3 billion | US$0.2 billion |
| Net cash provided by (used in) investing activities | US$-12.64 million | US$0.2 billion | US$-22.65 million | US$-28.65 million | US$-29.58 million |
| Net cash provided by (used in) financing activities | US$-75.58 million | US$-0.2 billion | US$-0.2 billion | US$-24.50 million | US$-51.48 million |
| Cash and cash equivalents | US$38.51 million | US$0.1 billion | US$72.65 million | US$0.3 billion | US$0.4 billion |
Revenue scale in the same industry
V2X
Engineering, accounting, research and management services: 11 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 Iqvia HoldingsFY Dec 2025 US$16.3B
- 2 AecomFY Sep 2025 US$16.1B
- 3 Booz Allen Hamilton HoldingFY Mar 2026 US$11.2B
- … 2 companies
- 6 Tetra TechFY Sep 2025 US$5.4B
- 7 IncyteFY Dec 2025 US$5.1B
- 8 V2XThis companyFY Dec 2025 US$4.5B
- 9 Charles River Laboratories InternationalFY Dec 2025 US$4.0B
- 10 FTI ConsultingFY Dec 2025 US$3.8B
- … 1 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$11.92 million | Consolidated | Disclosed |
| Cash and cash equivalents | US$0.4 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-51.48 million | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-29.58 million | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$0.2 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$16.98 million | Consolidated | Disclosed |
| Net assets | US$1.1 billion | Consolidated | Disclosed |
| Net sales | US$4.5 billion | Consolidated | Disclosed |
| Operating income | US$0.2 billion | Consolidated | Disclosed |
| Net income | US$77.88 million | Consolidated | Disclosed |
| Total assets | US$3.3 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$30.00 million | Consolidated | Disclosed |
| Operating margin | 4.3% | Consolidated | Calculated |
| Net assets to total assets | 33.1% | Consolidated | Calculated |
| Net margin | 1.7% | Consolidated | Calculated |
| Return on equity | 7.2% | Consolidated | Calculated |